Nath Bio-Genes (India) Limited announced strong Q1 FY2026 results with revenue increasing 14.9% to ₹280.17 crore and net profit rising 12.7% to ₹38.21 crore compared to the same period last year. Operating profit grew 4.7% to ₹37.93 crore. The company's Board approved the appointment of Ms. Payal Jain as an Additional Director, pending shareholder approval for her role as Independent Director.